Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Quaterly
Sun Pharma Advanced Research Company Ltd.
BSE Code 532872
ISIN Demat INE232I01014
Book Value (Rs) 7.15
NSE Code SPARC
Dividend Yield % 0.00
Market Cap(Rs Mn) 71232.49
TTM PE(x) 0.00
TTM EPS(Rs) -11.20
Face Value (Rs) 1  
Type: Quarters :
(Rs. in Million)
Particulars(Rs in Millions)Dec 2023Sep 2023
Audited / UnAudited UnAudited UnAudited
 Net Sales 138.60 211.80
 Total Expenditure 1164.80 1126.50
 PBIDT (Excl OI) -1026.20 -914.70
 Other Income 63.90 84.90
 Operating Profit -962.30 -829.80
 Interest 2.60 2.60
 Exceptional Items 0 0
 PBDT -964.90 -832.40
 Depreciation 31.60 31.80
 Profit Before Tax -996.50 -864.20
 Tax 0 0
 Provisions and contingencies 0 0
 Profit After Tax -996.50 -864.20
  Extraordinary Items 0 0
  Prior Period Expenses 0 0
  Other Adjustments 0 0
 Net Profit -996.50 -864.20
 Minority Interest 0 0
 Shares of Associates  
 Other related items  
 Misc. Expenses Written off 0 0
 Consolidated Net Profit -996.50 -864.20
 Equity Capital 324.50 324.50
 Face Value (IN RS) 1.00 1.00
 Reserves 0 0
 Calculated EPS -3.07 -2.66
 Calculated EPS (Annualised) -12.28 -10.65
 No of Public Share Holdings 111406493.00 111406493.00
 % of Public Share Holdings 34.33 34.33
    
 PBIDTM% (Excl OI) -740.40 -431.87
 PBIDTM% -694.30 -391.78
 PBDTM% -696.18 -393.01
 PBTM% -718.98 -408.03
 PATM% -718.98 -408.03
  Notes Notes